UK Product Approvals: J&J Expands Sudafed And Nicorette Offerings
Executive Summary
The UK's MHRA has approved the Rx-to-OTC switch of J&J's Sudafed Plus nasal spray (xylometazoline hydrochloride/dexpanthenol) and given the green light for the company to add new pack sizes to its Nicorette QuickMist and QuickMist Smart Track products.
You may also be interested in...
J&J Brings Innovative Combo Nasal Spray To UK
Following an Rx-to-OTC switch last year, J&J has launched its innovative dexpanthenol and xylometazoline combination nasal spray Sudafed Plus Blocked Nose in UK pharmacies.
J&J’s Nicorette Becomes World’s First Licensed Vaping And Smoking Cessation Therapy
J&J's OTC nicotene replacemnt therapy brand Nicorette goes from strength to strength in the UK with a world-first approval from the country's medicines regulator for its Quickmist product for vaping cessation.
J&J Pulls Plug On Talc Across Its Baby Powder Portfolio, Shifts To Cornstarch-Based Products
As it did when it halted sales in US and Canada in 2020, J&J’s latest announcement attributes its decision as coming from a “portfolio assessment” and stated it remains confident in using talc in baby powder and cosmetics.